Skip to main content
NEWS EVENTS CAREERS
CONNECT
NEWS EVENTS CAREERS CONNECT

Make your complex medicine here with confidence.

RESI-24-003d 3DKA _ 08 DS_Pesrp01 1-2

Nothing in this industry ever stays the same. So we've evolved too.

We've expanded our strengths while keeping quality, speed, and sustainability front and center to build a more resilient tomorrow, today. Resilience is bringing together brilliant minds in science and engineering with access to advanced technologies and right-first-time performance at scale.

Facilities

Resilience is North America based, with facilities across the continental US and Canada. Our regulatory expertise spans across global markets and serves customers in the EU, Asia, the Middle East, and North America.

Custom solutions to fit your needs

We were founded with a straightforward yet bold purpose: to broaden access to complex medicines and to protect biopharmaceutical supply chains against disruption. At the heart of our approach is a network of high-tech, end-to-end drug substance and drug product manufacturing solutions that can help ensure the medicines of today and tomorrow can be made quickly, safely, sustainably, and at scale.

*Photo captured in aseptic training environment.

Earning Trust One Dose at a Time

Our dedication to quality drives everything we do. Our unwavering commitment comes to life
through the delivery of more than 100 million vials and pre-filled syringes each year.

Commercial readiness

100% pass rate for third-party and EU Annex 1 assessments.

Successful inspections

USFDA cGMP
USFDA PAI
USFDA PFS & Vial Approval
Health Canada
EMA Virtual Inspection
RESI-24-003d-3DKA-_-08-DS_Pesrp01_WF_black_cropped

What's new at Resilience

scroll
Filter
Post icon
November 20, 2025
Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy
Press Release . Biomanufacturing . Drug Product . Sterile Fill/Finish . In The News . Financing
Post icon
November 20, 2025
Redefining CAR-T Speed and Strength with DAR-T™: A Conversation with Nicholas Kirian
Cell Therapy . Technology . Resources
Post icon
October 29, 2025
Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy
Press Release . Biomanufacturing . Drug Product . Sterile Fill/Finish . In The News . Financing
Post icon
July 11, 2025
How integrated data systems enhance clinical development and manufacturing
Biomanufacturing . Tech Transfer . Technology . Development
Post icon
June 27, 2025
CDMOs Are Making Their Supply Chains More Resilient & Secure
Biomanufacturing . In The News . Development
Post icon
June 05, 2025
Navigating the Evolving Landscape of Fill/Finish: Trends, Challenges, and What’s Ahead
Biomanufacturing . Drug Product
Post icon
May 08, 2025
On Demand Webinar:  Fill/Finish Services - Outsourced Pharma Capacity Update
Biomanufacturing . Drug Product . Sterile Fill/Finish . Webinar
Post icon
May 06, 2025
Cell Therapy Innovations: Reducing Costs to Improve Patient Access
Cell Therapy . Biomanufacturing
Post icon
March 28, 2025
Executive Interview: Advancing Therapies That Transform Lives
Company Culture
Post icon
March 26, 2025
Resilience and JobsOhio Announce Continued Partnership and Expansion in Blue Ash
Press Release . Biomanufacturing . Drug Product . In The News . Partnerships
Post icon
January 30, 2025
Presentation: Rapid Multi-Omics Cell Therapy Characterization and QC
Cell Therapy . Technology . Presentation . Resources
Post icon
January 29, 2025
Whitepaper: 3-Day Short Cycle CAR-T Manufacturing Process
Cell Therapy . Technology . White Paper . Resources
Post icon
January 15, 2025
Resilience is proud to support CARGO Therapeutics' novel allogeneic CAR-T cell therapy
Press Release . In The News . Media Coverage
Post icon
January 14, 2025
Presentation: Expedited Cell Therapy QC: Sample in, to QC Report in 48 Hours 
Cell Therapy . Technology . Presentation . Resources
Post icon
January 08, 2025
Resilience Partners with Parvus Therapeutics for Development and Manufacturing of PVT401, a Novel Autoimmune Drug Candidate for IBD
Press Release . In The News . Media Coverage
Post icon
December 05, 2024
Resilience Announces Appointment of William S. Marth, RPh., MBA as Chief Executive Officer
Press Release . Company Culture . In The News . Media Coverage
Post icon
November 05, 2024
On-Demand Webinar: Outsourced Pharma Capacity Update - Drug Substance
Biologics . Facilities . Webinar . Presentation . Drug Substance
Post icon
October 28, 2024
Key Steps in the Vaccine Scale-up Journey
Vaccines . Regulatory
Post icon
October 03, 2024
Resilience Secures Funding to Expand Domestic Manufacturing for Critical Pharmaceutical Ingredients
Press Release . Biomanufacturing . In The News . Media Coverage . Government/NGO
Post icon
September 30, 2024
Resilience Appoints Dr. Susan Billings, Chief Commercial Officer
Press Release . Company Culture . In The News . Media Coverage
Post icon
July 10, 2024
Boston, MA: Process & Analytical Development and Manufacturing Facility
Vaccines . Biologics . Facilities . Gene Therapy . Process and Analytical Development . Resources
Post icon
July 01, 2024
On-Demand Webinar: Outsourced Pharma Capacity Update - Fill/Finish
Drug Product . Sterile Fill/Finish
Post icon
June 27, 2024
On-Demand Presentation: Improving cell line development in CHO with a focus on product manufacturability
Biologics . Presentation . Resources
Post icon
June 27, 2024
Meet the Team: Viral Vector Development & Manufacturing
Gene Therapy . Biomanufacturing . Tech Transfer . Company Culture . Process and Analytical Development
Post icon
June 05, 2024
Alachua Campus Tour Video
Government/NGO
Post icon
May 02, 2024
Revised Annex 1 and the Focus on Microbial Control Strategies
Biomanufacturing . Drug Product . Regulatory . Sterile Fill/Finish . Resources
Post icon
April 25, 2024
Starburst Data Rebel Awards: Data Product of the Year
In The News . Awards . Technology
Post icon
March 25, 2024
Building Velocity into Fill/Finish Timelines: Your Guide to Quality and Regulatory Success in the CDMO Space
Biomanufacturing . Drug Product . Tech Transfer . Sterile Fill/Finish . Resources
Post icon
March 07, 2024
On-Demand Webinar: Outsourced Pharma Capacity Update 2024 - Large Molecules
Vaccines . Biologics . Facilities . Biomanufacturing . Drug Product . Tech Transfer . Process and Analytical Development
Post icon
February 23, 2024
On-demand Webinar: Optimize research and delivery of complex medicines using data insights
Webinar . Partnerships . Technology
Post icon
February 20, 2024
Resilience Expands Clinical and Commercial Drug Product Manufacturing Capabilities and Capacities
Press Release . In The News . Partnerships
Post icon
February 19, 2024
Scale Your Vaccine Development with Path-to-PAD
Vaccines . Process and Analytical Development
Post icon
February 13, 2024
How Resilience Is Bringing Forward Thinking to Disrupt the Biomanufacturing Landscape to Increase Access to Medicines
Company Culture
Post icon
February 05, 2024
National Resilience and Taiwan Bio-Manufacturing Corporation Announce Groundbreaking Partnership in Biomanufacturing Innovation
Press Release . In The News . Partnerships
Post icon
January 11, 2024
Successful Development and Manufacturing of Vaccines Containing Aluminum Adjuvants
Vaccines . Sterile Fill/Finish
Post icon
January 04, 2024
Developing New Medicines Through Artificial Intelligence
Technology . Artificial Intelligence . Protein-Engineering
Post icon
January 04, 2024
Resilience to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Press Release . In The News
Post icon
December 21, 2023
The Stage-Gate Model: A Proven Approach to Streamline Biomanufacturing
Tech Transfer . Technology . White Paper . Resources
Post icon
December 20, 2023
Resilience builds lab supply chain tracking platform on AWS
Biomanufacturing . Partnerships . Technology
Post icon
December 12, 2023
On-demand Video: Efficiency Meets Economy: The Power of Single-Use Chromatography in mAb Purification
Biologics
Post icon
December 11, 2023
Resilience Announces Expansion in West Chester
Press Release . In The News . Partnerships
Post icon
November 30, 2023
How digital twins help improve biomanufacturing quality and security
Digital Twins . Technology
Post icon
November 17, 2023
On-demand Video: Idea to Clinic – Aim to Reduce your Manufacturing Timeline by ~30%
Biologics . Biomanufacturing
Post icon
November 07, 2023
Resilience Appoints Bill Marth as President of Services
Press Release . Partnerships
Post icon
October 26, 2023
Accelerating Clinical Timelines of Induced Pluripotent Stem Cells (iPSCs) with Pluristyx
Cell Therapy . Biomanufacturing . In The News . Partnerships
Post icon
October 03, 2023
BridgeBio and Resilience Announce Strategic Multi-Year Partnership
Press Release . Partnerships
Post icon
August 29, 2023
The Challenges and Solutions for Viral Products
Vaccines . Biomanufacturing
Post icon
August 28, 2023
How Early-Phase Companies Can Future-Proof Their Cell Therapies
Cell Therapy . Process and Analytical Development
Post icon
August 28, 2023
Resilience Announces Joint Venture with Lifera in Saudi Arabia
Press Release . Partnerships
Post icon
July 13, 2023
Opening of Resilience's West Coast Cell Therapy PAD Center
Cell Therapy . Biomanufacturing . In The News
Post icon
July 12, 2023
On-Demand Webinar: High-Throughput Process & Analytical Platforms to Accelerate Gene Therapy Scale-Up
Gene Therapy . Process and Analytical Development
Post icon
July 05, 2023
Overcoming Obstacles in Gene Therapy Manufacturing
Gene Therapy . Biomanufacturing
Post icon
May 23, 2023
On-Demand Webinar: Future-Proof Your Aseptic Filling
Webinar
Post icon
May 16, 2023
Resilience Enters Into Strategic Collaboration with Labcorp to Accelerate Cell and Gene Therapies
Cell Therapy . Gene Therapy . Biomanufacturing
Post icon
May 11, 2023
Problem Solving for Aseptic Filling
Drug Product . Sterile Fill/Finish
Post icon
May 08, 2023
On Demand Webinar: Outsourced Pharma Capacity Update-Large Molecules
Vaccines . Biologics . Facilities . Biomanufacturing . Drug Product . Tech Transfer . Process and Analytical Development
Post icon
May 04, 2023
Leveraging Partnerships to Achieve Cell Therapy Success
Cell Therapy . Biomanufacturing
Post icon
April 03, 2023
Master Cell Banks: Laying the Foundation to Final Product Success
Gene Therapy . Biomanufacturing
Post icon
March 24, 2023
Resilience Approved For $410M Financing From The Department Of Defense, In Partnership With The Development Finance Corporation, To Establish Resilient Biomanufacturing Capacity
Press Release . Financing
Post icon
March 23, 2023
Looking Ahead: What Does the Future Have in Store for Nucleic Acid-Based Therapies?
Nucleic Acids
Post icon
February 16, 2023
Resilience Signs Multi-Year Strategic Biomanufacturing Partnership With Leading Pharmaceutical Company
Press Release
Post icon
January 25, 2023
Alachua Biomanufacturing Expansion Video
Vaccines . Biologics . Gene Therapy . Biomanufacturing . Drug Product . Tech Transfer . Sterile Fill/Finish
Post icon
January 10, 2023
Resilience Announces Equity Investment From Mubadala And Funding Of New Biopharma Manufacturing Facility In The United Arab Emirates
Press Release
Post icon
January 03, 2023
Resilience to Establish Biomanufacturing Partnership with AstraZeneca and Purchase Manufacturing Site
Vaccines . Biologics . Biomanufacturing . Sterile Fill/Finish
Post icon
November 29, 2022
Cell Therapy – What Does It Take To Become a Mainstream Option
Cell Therapy . Biomanufacturing . Resources
Post icon
November 29, 2022
On Demand Drug Substance Manufacturing and Drug Product Fill/Finish Solutions Presentation
Biologics . Biomanufacturing . Drug Product . Tech Transfer . Sterile Fill/Finish . Process and Analytical Development . Webinar
Post icon
November 29, 2022
Resilience To Establish A Biomanufacturing Partnership With AstraZeneca And Purchase AstraZeneca’s Manufacturing Site In West Chester, Ohio
Press Release
Post icon
October 12, 2022
National Resilience Honored By Goldman Sachs For Entrepreneurship
Press Release
Post icon
October 05, 2022
On-Demand Webinar: Establishing a Stage-Gate Approach to Biomanufacturing
Webinar
Post icon
August 23, 2022
Resilience Becomes Biomanufacturing Resource Partner For California Institute For Regenerative Medicine
Press Release
Post icon
August 15, 2022
Resilience Announces Collaboration To Manufacture And Deliver Biotherapeutics For Rare And Complex Conditions
Press Release . Partnerships
Post icon
June 08, 2022
The Parker Institute For Cancer Immunotherapy And Resilience Announce Strategic Alliance To Develop Next-Generation Cancer Therapies
Press Release . Partnerships
Post icon
June 06, 2022
Resilience Announces $625 Million Series D Financing To Expand Network, Bring Innovative Technologies To Biomanufacturing
Press Release
Post icon
June 02, 2022
Resilience And MD Anderson Launch Joint Venture To Accelerate Development And Manufacturing Of Innovative Cell Therapies For Cancer
Press Release . Partnerships
Post icon
February 15, 2022
Resilience Establishes Multi-Product Development And Manufacturing Collaboration With Takeda’s Plasma-Derived Therapies Business Unit
Press Release
Post icon
February 09, 2022
Resilience Subsidiary Ology Bioservices Awarded Contract Worth Up To $250 Million From U.S. Department Of Defense For Botulinum Neurotoxin Treatment
Press Release
Post icon
December 02, 2021
Resilience Acquires SwiftScale Biologics, A Leader In Cell-Free Protein Synthesis Technology
Press Release
Post icon
October 15, 2021
Resilience And Harvard University Announce Five-Year R&D Alliance To Incubate New Technologies, Launch Companies To Advance The Manufacture Of Complex Medicines
Press Release . Partnerships
Post icon
October 12, 2021
Resilience Joins Forces With Children’s Hospital Of Philadelphia To Develop Next-Generation Biomanufacturing Technologies, Create Impactful Therapies
Press Release
Post icon
September 08, 2021
Resilience To Manufacture mRNA For Moderna’s COVID-19 Vaccine
Press Release
Post icon
August 02, 2021
Meet The 24 Biotech Startups That Top VCs Say Are Poised To Take Off In The next 12 Months
In The News
Post icon
July 28, 2021
Bluebird Bio And Resilience Announce Strategic Alliance To Develop Next Generation Cell Therapies
Press Release
Post icon
May 18, 2021
Resilience Receives USD $164 Million Investment From The Government of Canada to Modernize and Expand Its Ontario Biomanufacturing Site, Improving Pandemic Preparedness
Press Release . Financing
Post icon
April 12, 2021
Resilience Continues Expansion With Acquisition Of Biologics Manufacturing Company Ology Bioservices
Press Release
Post icon
March 03, 2021
How An East Bay Site May Lead A Biotech Manufacturing Revolution
Press Release
Post icon
March 02, 2021
With Stars Aligned And Cash In Reserve, Bob Nelsen’s Resilience Plans A Makeover At 2 New Facility Additions To Its Drug Manufacturing Upstart
Press Release
Post icon
March 02, 2021
Resilience Expands North American Capacity With The Acquisition Of Two Premier Biologics Manufacturing Facilities
Press Release
Post icon
February 16, 2021
Fireside Chat With Rahul Signhvi, CEO Of Resilience
Press Release
Post icon
February 15, 2021
Resilience Bags Sanofi-Genzyme Plant In Boston
Press Release
Post icon
February 11, 2021
Sanofi Prepares To Transfer Allston Plant To A New Company, But Not Its City Tax Breaks
Press Release
Post icon
November 30, 2020
Raging At The Pandemic, A VC Raises $800M For A Company That Aims To Transform Biotech Manufacturing
In The News
Post icon
November 23, 2020
Resilience Launches To Change The Future Of Medicine Through Manufacturing Innovation
Press Release
Vaccine-Graphic
resi-mobile-vaccine-1

The benefits of working with Resilience

When you engage with Resilience, you get more than a CDMO. It gives you a catalyst for innovation. Our strategic thinking and exceptional expertise work in tandem to future-proof the next stages of your discovery. Through three defining advantages, we help your team move science from potential to breakthrough.

01.

Commitment to Safety, Quality, Regulatory

De-risk regulatory filings through a digital, real-time quality management system built for transparency and control.

02.

Customer Centricity

Drive safer, faster, and smarter project delivery with our proven stage-gate approach backed by expert PM and Technical Lead advocacy.

03.

Manufacturing

Building out one of the largest, most advanced sterile injectable & device assembly/packaging operations in North America.

Upcoming events

Contact Us
chevrons-pattern-black-1

RESILIENCE